This Small Oil Producer is Ripe for a Takeover… Here’s How to Profit

by Sheena Martin, Contributing Editor Friday, November 20, 2009

Takeovers are big news in the market at the moment.

In fact, did you know that takeovers have the biggest one-day gain in stocks for any asset?

As my colleague – and takeover expert – Louis Basenese says, they’re “some of the safest companies you can own. According to FactSet Merger Stat LLC, the average one-day return for shareholders of the target company is 48%.”

Furthermore, Louis says, “Industries naturally go through cycles of consolidation – waves of mergers, acquisition and takeovers.”

One industry riding this wave as it comes out of recession is oil. And I have a takeover target making strides in oil exploration that could put money in your pocket in a few months

...

Doctor Up Your Portfolio With This Medical Communications Company

by Louise Harris, Investment U Research

The healthcare reform debate continues to swirl in Washington. And Marc Lichtenfeld and Louis Basenese have discussed this crucial topic recently, offering their thoughts on the companies best positioned to profit.

That’s because regardless of the back-and-forth and political slanging match, the healthcare sector still offers strong potential for solid returns, due to skyrocketing demand.

In particular, one small-cap poised for gains is the Utah-based firm ZYTO Corp. (OTC: ZYTC). It focuses on medical communication software and services, including an operating system that transfers information from computers to humans.

But ZYTO goes beyond simple data input. It uses patent-pending methods that monitor biological states in near-real time, creating a stimulus-response experience called a bio-survey.

(Translation: It reads life signs and converts them into easily readable

...

For the first time in six months, retail sales ticked higher in August.

Granted, it wasn’t by much – a scant 0.7% higher than July. But it’s inevitable that consumers will eventually get back to their spending ways as this recession subsides.

And if you’re looking for a way to play it, consider hhgregg, Inc. (NYSE: HGG). Here’s why…

hhgregg, Inc: This Retailer is Bucking the Industry Trend

Based in Indianapolis, the hhgregg operates 111 retail stores selling consumer electronics and home appliances. Yes, I know that’s the same stuff you can get at your typical Best Buy (NYSE: BBY), Home Depot (NYSE: HD), or Lowe’s (NYSE: LOW).

But this company is hardly typical.

While most retailers are focused on survival, hhgregg’s in full-on attack mode. It’s not pinching pennies to stay afloat. It’s not reducing the workforce. It’s not closing underperforming stores, or mothballing expansion

...

hhgregg, Inc. (NYSE: HGG): The Only Retail Stock Worth Buying Right Now

by Louis Basenese, Advisory Panelist

For the first time in six months, retail sales ticked higher in August.

Granted, it wasn’t by much – a scant 0.7% higher than July. But it’s inevitable that consumers will eventually get back to their spending ways as this recession subsides.

And if you’re looking for a way to play it, consider hhgregg, Inc. (NYSE: HGG). Here’s why…

hhgregg, Inc: This Retailer is Bucking the Industry Trend

Based in Indianapolis, the hhgregg operates 111 retail stores selling consumer electronics and home appliances. Yes, I know that’s the same stuff you can get at your typical Best Buy (NYSE: BBY), Home Depot (NYSE: HD), or Lowe’s (NYSE: LOW).

But this company is hardly typical.

While most retailers are focused on

...

America’s Smart Grid: Four Companies Set to Profit from a Federal Cash Injection

by David Fessler, Advisory Panelist

What do Cisco Systems (Nasdaq: CSCO), IBM (NYSE: IBM), AT&T (NYSE: T) and Intel (Nasdaq: INTC) all have in common?

The obvious answer is that they’re four of the most successful technology companies on the planet.

But they’re also heavily involved in the modernization plans for America’s “Smart Grid” – a topic I introduced in a previous column.

Make no mistake, with a decade-long project as monumental as modernizing the country’s “Smart Grid,” the devil is truly in the details. And the Commerce Department released the finer details of the initiative last week.

Until now, one of the big problems with the “Smart Grid” was the lack of set standards. Without them, each power company would be free to do

...

Another Monday… Another “Game-Changing” Deal

by Martin Denholm, Senior Editor

Monday is Merge Day.

A few weeks ago, the market saw the busiest day of deal-making in three months, as the news-wires lit up with news of several big takeover announcements, including Walt Disney (NYSE: DIS) buying Marvel (NYSE: MVL).

It happened again the following week. In fact, over a 10-day period, more than $40 billion worth of deals were announced.

And even as the third quarter winds down, the pace is still frenetic in the M&A market.

Today saw technology equipment firm Xerox (NYSE: XRX) announce a $6.4 billion deal to buy Affiliated Computer Services (NYSE: ACS) – its biggest acquisition on record.

Xerox investors greeted the news with a collective “ugh,” as shares of the photocopying and business supplies giant spiraled down by 17%. While perhaps

...

When it comes to the healthcare debate, let’s keep one obvious fact in mind: Expenses are out of control and must be reined in. That’s true with or without a massive reform bill.

And that plays right into the hands of Medidata Solutions Inc. (Nasdaq: MDSO).

The company is a leading provider of electronic data capture (EDC) and clinical data management systems (CDMS). In laymen’s terms, it helps drug companies go from the Dark Age into the Digital Age.

And it’s a transformation that we desperately need. Here’s why…

Anyone For a Tedious, Time-Consuming Paper Trail?

Roughly 75% of all clinical trials – the most critical function of drug companies, yet also the biggest drain on resources ($45 billion, annually) – are done on paper.

That’s right. Even in today’s high-tech world, in three out of four clinical trials, information for each patient is literally recorded on pre-printed paper, specifically a case

...

Get Paid To Trade With Dividends

by Ryan Cole, Investment U Research

According to Wharton finance professor Jeremy Seigel, one of the more respected minds in economics, 97% of stock market gains come from one thing and one thing only.

Most people immediately assume one of three answers, but don’t fall to the same misconceptions that the masses do. Contrary to what you may think, the vast majority of stock market gains do not come from:

Capital Appreciation – The occasional home run aside, stock prices tend to even out over time, at only a little better rate than inflation. M&A activity – Most investors won’t see takeovers or mergers make any real difference in their overall portfolio. IPOs – Though IPOs do represent some of the largest single-day moves, the underlying stocks usually settle down into normal trading patterns fairly quickly.

Instead, 97% of all the gains the

...

Medidata Solutions: The One Healthcare Stock That’s Not Sucking Up to Washington

by Louis Basenese, Advisory Panelist

When it comes to the healthcare debate, let’s keep one obvious fact in mind: Expenses are out of control and must be reined in. That’s true with or without a massive reform bill.

And that plays right into the hands of Medidata Solutions Inc. (Nasdaq: MDSO).

The company is a leading provider of electronic data capture (EDC) and clinical data management systems (CDMS). In laymen’s terms, it helps drug companies go from the Dark Age into the Digital Age.

And it’s a transformation that we desperately need. Here’s why…

Anyone For a Tedious, Time-Consuming Paper Trail?

Roughly 75% of all clinical trials – the most critical function of drug companies, yet also the biggest drain on resources ($45 billion, annually) – are done

...

The “Tiregate” Scandal Can’t Derail This Growth Story…

by Robert Williams, Publisher, Investment U

The 35% tariff that President Obama just slapped on Chinese tire imports is not sitting well with the nation’s top brass, notably President Hu Jintao.

Chinese officials say that the tire decision represents a dangerous precedent toward protectionism and against the notion of free trade. They’re even threatening to “re-evaluate” their position on U.S. imports, like automobiles and poultry.

But Tiregate is more about the United Steelworkers union – the dominant force in U.S. tire plants – than anything else. The union is a pivotal ally in Obama’s fight on healthcare reform.

As such, I expect the spat to resolve itself at the upcoming G-20 summit in Pittsburgh. So don’t let this tit-for-tat derail your long-term investment outlook on China.

The rise of the middle

...